Research Paper Volume 16, Issue 9 pp 7774—7798
The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma
Figure 4. Survival curves (A–G) comparing the survival between different risk groups based on MPIGs across various datasets.